Adage Capital Management logo

Adage Capital Management

North America, Massachusetts, United States, Boston

Description

Adage Capital Management focuses on managing S&P 500 assets predominantly for endowments and foundations.

Investor Profile

Adage Capital Management has backed more than 129 startups, with 8 new investments in the last 12 months alone. The firm has led 10 rounds, about 8% of its total and boasts 87 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series B, Series C rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom, Canada.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Post Ipo Equity (40%)
  • Series B (19%)
  • Series C (14%)
  • Series Unknown (8%)
  • Series D (8%)
  • Private Equity (3%)
  • Series F (3%)
  • Series A (2%)
  • Series E (2%)
  • Series H (2%)

Country Focus

  • United States (88%)
  • United Kingdom (3%)
  • Canada (3%)
  • Australia (2%)
  • France (2%)
  • Switzerland (1%)
  • China (1%)
  • Israel (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Biopharma
  • Life Science
  • Health Diagnostics
  • Genetics
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Adage Capital Management frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 16
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 16
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 14
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 33
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 18
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 15
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 13
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 13
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 24
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 16

Which angels does Adage Capital Management often collaborate with?

JR
North America, California, United States, San Francisco
Shared Deals: 1
AS
North America, United States
Shared Deals: 1
JP
North America, Virginia, United States, Great Falls
Shared Deals: 2

What are some of recent deals done by Adage Capital Management?

SCYNEXIS

Durham, North Carolina, United States

Scynexis engages in drug discovery, development and manufacturing projects in various areas.

BiotechnologyHealth CareManufacturingPharmaceutical
Post Ipo EquityMar 31, 2026
Amount Raised: $40,000,000
OnKure Therapeutics

Boulder, Colorado, United States

OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.

BiotechnologyLife SciencePrecision MedicineTherapeutics
Post Ipo EquityMar 27, 2026
Amount Raised: $150,000,000
Ovid Therapeutics

New York, New York, United States

Ovid Therapeutic's purpose is to solve intractable medical problems.

BiopharmaBiotechnologyHealth Care
Post Ipo EquityMar 17, 2026
Amount Raised: $60,000,000
Relmada Therapeutics

New York, New York, United States

Relmada Therapeutics is a biotech company addressing diseases of the central nervous system, with a focus on major depressive disorder.

BiotechnologyClinical TrialsPharmaceutical
Post Ipo EquityMar 9, 2026
Amount Raised: $160,000,000
Opus Genetics(formerly Ocuphire Pharma)

Farmington Hills, Michigan, United States

Opus Genetics a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.

BiopharmaBiotechnologyPharmaceutical
Post Ipo EquityFeb 13, 2026
Amount Raised: $25,000,000
CORXEL Pharmaceuticals

Shanghai, Shanghai, China

CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.

BiotechnologyHealth CareMedical
Series DJan 22, 2026
Amount Raised: $287,000,000
Mirador Therapeutics

San Diego, California, United States

Mirador Therapeutics develops precision medicines for immune-mediated diseases.

BiotechnologyHealth CareMedicalTherapeutics
Series BJan 12, 2026
Amount Raised: $250,000,000
Ambros Therapeutics

Irvine, California, United States

Ambros Therapeutics is a clinical-stage biotechnology company.

BiotechnologyMedicalTherapeutics
Series ADec 16, 2025
Amount Raised: $125,000,000
Pasithea Therapeutics

Miami Beach, Florida, United States

Pasithea Therapeutics is a biotechnology company that seeks to solve clinical problems such as mental health.

BiotechnologyHealth CareMental HealthTherapeutics
Post Ipo EquityNov 28, 2025
Amount Raised: $60,000,000
SeraGene Therapeutics

Vancouver, British Columbia, Canada

SeraGene Therapeutics is a biotechnology company that offers treatment for coagulation disorders through nanomedicine technologies and RNA.

BiotechnologyHealth CareTherapeutics
SeedNov 19, 2025

Find More Investors Like Adage Capital Management

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides